1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Asia Pacific Bioreactors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Cell ; Molecule ; Technology ; End User and Country

Asia Pacific Bioreactors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Cell ; Molecule ; Technology ; End User and Country

  • June 2020
  • 150 pages
  • ID: 5915396
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The Asia Pacific bioreactors market is expected to reach US$ 994.52 Mn by 2027 from US$ 544.51 Mn in 2019. The market is estimated to grow at a CAGR of 7.9% from 2020 to 2027.The growth of the marketin this region is primarily attributed to the escalating demand for bioreactors and rising number of market players focusing on expanding their business in different countries, rapidly growing biopharmaceutical and biotechnology industries, and increasing adoption of single-use bioreactors. However, stringent regulatory framework is the major factor hindering the market growth in Asia Pacific. Additionally, technological advancements in bioreactors and rising demand of personalized medicinesare the factors that are likely boost the growth of the bioreactorsmarketin this region during the forecast period.
A bioreactor is equipment or system engineered to provide biologically active environment for the production of various medical and pharmaceutical compounds.The vessel is used to carry out a chemical process, which involves organisms or biochemically active substances derived from such organisms.

This process can either be aerobic or anaerobic.Bioreactors are commonly cylindrical in shape, ranging in capacities from liters to cubic meters, and are generally made of stainless steel.

Bioreactors provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress. These equipment are used in a variety of applications, such as production of biopharmaceuticals and tissue engineering products.
The biopharmaceutical industry is one of the most significant contributors to many economies.With the aging population and rising healthcare standards,the demand for pharmaceutical products has been escalating in Asia Pacific countries.

For instance, Autekbio, based in Beijing,is one of the few biopharmaceutical manufacturing organizations fully devoted to contract manufacturing of biologicals.TaiMed Biologics Ibalizumab, the FDA-designated orphan drug, is manufactured by contract pharmaceutical manufacturing WuXi PharmaTech.

With the increasing demand for drugs and pharmaceuticals, many companies are opting for advanced bioreactor-related specialized services offered by other pharmaceuticals and biotechnology companies; this enables them to speed up the development process and attain lower production costs.Apart from developed economies, emerging economies such as Brazil, China, and India have shown rapid growth in the research landscape.

Factors such as increasing approvals for biologics, growing pipeline of biosimilars, and elevating investments in research activities are prime factors facilitating the growth of the bioreactor industry in this region. Moreover, increasing approvals in gene and cell therapies are favoring the growth of the market. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency, and Strimvelis- treating ADA-Severe Combined Immunodeficiency.
The ongoing COVID-19 pandemic has badly affected the transportation infrastructure in Asia Pacific, resulting in disruptions in supply chains and shortage of healthcare facilities in low-income countries.To prevent the spread of disease, restrictive measures have been taken in South Korea, Malaysia, Singapore, the Philippines, and India.

The COVID-19 outbreak is expected to have short- and long-term impact on the region,which is potentially projected to have negative impact on growth of the bioreactors market in the region.
In 2019, the mammalian cells segment accounted for the largest share of the Asia Pacific bioreactors market.However, the yeast cells segment is expected to register the highest CAGR during the forecast period.

Yeasts are cost-effective, fast-growing, and technically feasible and can be used for high-density cell cultures in bioreactors. Moreover rapid growth rate, easy genetic manipulation, complete genome sequence knowledge, cost-effective growth medium requirements, and post-translational modifications flexibility make yeasts perfect hosts for recombinant protein expression.
A few of the significant secondary sources referred to while preparing the report on the Asia Pacific bioreactors marketreport includethe World Health Organization (WHO) andMedical Research Future Fund (MRFF).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on